Urol. praxi. 2023;24(1):45-47 | DOI: 10.36290/uro.2023.019

Renal cell carcinoma in the testicle

MUDr. Veronika Lounová1, MUDr. Igor Hartmann, Ph.D.1, MUDr. Hana Študentová, Ph.D.2
1 Urologická klinika FN a LF UP Olomouc
2 Onkologická klinika FN a LF UP Olomouc

Renal cell carcinoma predominantly metastasizes through haematogenous spread. It has been shown experimentally that clear-cell renal cell carcinoma can bypass the primary sites of metastasis formation and establish metastases directly at atypical sites. Testicular metastases are generally very rare, accounting for less than 1% of all testicular tumours. A metastasis may occasionally mimic a primary testicular tumour. A rare case is reported of clear-cell renal cell carcinoma in the testicle, the primary origin of which can only be debated of.

Keywords: renal cell carcinoma, metastases, primary locus, testicular tumour.

Accepted: March 16, 2023; Published: March 21, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lounová V, Hartmann I, Študentová H. Renal cell carcinoma in the testicle. Urol. praxi. 2023;24(1):45-47. doi: 10.36290/uro.2023.019.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. O nádorech ledvin >> Linkos.cz. Linkos: Česká onkologická společnost České lékařské společnosti J. E. Purkyně >> Linkos.cz [online]. Copyright © 2021 ČOS ČLS JEP [cit. 29. 09. 2021]. Dostupné z: https://www.linkos.cz/pacient­‑a-rodina/onkologicke­‑diagnozy/nadory­‑ledviny­‑a-mocoveho­‑mechyre­‑c64-c67/o­‑nadorech­‑ledvin/.
    2. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre­‑metastatic niche. Nature. 2005;438(7069):820-827. Go to original source... Go to PubMed...
    3. Sountoulides P, Metaxa L, Cindolo L. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep. 2011;5:429. Go to original source... Go to PubMed...
    4. Ulbright TM, Young RH. Metastatic carcinoma to the testis: a clinicopathologic analysis of 26 nonincidental cases with emphasis on deceptive features. Am J Surg Pathol. 2008;32(11):1683-1693. Go to original source... Go to PubMed...
    5. Thomas AZ, McDermott TE, Crowther S, Thornhill JA. Primary clear cell carcinoma of the rete testis: 1st report. BMJ Case Rep. 2015;2015:bcr2014209000. Go to original source... Go to PubMed...
    6. Kumar RM, Aziz T, Jamshaid H, et al. Metastatic renal cell carcinoma without evidence of a primary renal tumour. Curr Oncol. 2014;21(3):e521-524. Go to original source... Go to PubMed...
    7. Wang G, Zhou C, Villamil CF, et al. Metastatic Renal Cell Carcinoma to the Testis: A Clinicopathologic Analysis of Five Cases. Case Rep Pathol. 2020;2020:9394680. Go to original source... Go to PubMed...
    8. Zeh N, Wild PJ, Bode PK, et al. Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum­‑based chemotherapy. BMC Urol. 2013;12:13:9. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.